Silvia Koder - Concepedia

Concepedia

Author

Silvia Koder

Medical University of Vienna

Also Known As

F Prller, Gebhart, Johanna, J Gebhart, Koder, Silvia, Panzer, Simon, S Koder, S. Koder, Silvia Koder

57

Publications

1.6K

Citations

22

H-Index

39

Concepts

All Affiliations

Medical University of Vienna University of North Carolina at Chapel Hill Statistics Austria Medical University of Graz Goethe University Frankfurt

SK

About

Silvia Koder is an author at Medical University of Vienna specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	295
2	Public Health	4	4	139
3	Epidemiology	4	4	139
4	Allergy	1	1	27
5	Cell Biology	1	1	51

Silvia Koder

×

29

Publications

1.6K

Citations

22

H-Index

	Year	Citations
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Cihan Ay, Ralph Simanek, Rainer Vormittag, Blood	2008	415
Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study Cihan Ay, Daniela Dunkler, Ralph Simanek, Journal of Clinical Oncology	2011	222
High Concentrations of Soluble P-Selectin Are Associated with Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant Cihan Ay, Lea Jungbauer, Thomas Sailer, Clinical Chemistry	2007	129
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) Johanna Gebhart, Florian Posch, Silvia Koder, Blood	2015	69
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden Ingrid Pabinger, László Nemes, C. Rintelen, The Hematology Journal ThrombosisInfertilityVenous ThrombosisMaternal Cardiovascular OutcomeHematology	2000	67
The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study Hanna Lena Obermeier, Julia Riedl, Cihan Ay, Research and Practice in Thrombosis and Haemostasis	2019	55
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS) Florian Posch, J. Thaler, Gerhard J. Zlabinger, Clinical Cancer Research	2015	53
Association of platelet activation markers with cancer-associated venous thromboembolism Julia Riedl, Lena Hell, Alexandra Kaider, Platelets	2015	51
Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation J. Thaler, Silvia Koder, Gabriela Kornek, Translational research Pancreatic CancerMedicinePathologyFibrinolysisFibrin Clot Formation	2013	51
Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause Stefanie Hofer, Cihan Ay, Judit Rejtő, Journal of Thrombosis and Haemostasis	2019	51

Page 1